{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T22:29:08Z","timestamp":1788820148075,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,23]]},"DOI":"10.7759\/cureus.12880","type":"journal-article","created":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T17:45:37Z","timestamp":1611423937000},"source":"Crossref","is-referenced-by-count":3,"title":["Delusional Infestation Secondary to the Dopamine Agonist Ropirinole in a Patient With Parkinson's Disease: A Case Report With an Outline of the Biology of Psychosis"],"prefix":"10.7759","author":[{"given":"Hassan","family":"Kesserwani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00018-09","article-title":"Delusional infestation","volume":"22","author":"Freudenmann RW","year":"2009","unstructured":"Freudenmann RW, Lepping P. Delusional infestation. Clin Microbiol Rev. 2009, 22:690-732. 10.1128\/CMR.00018-09","journal-title":"Clin Microbiol Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(96)00187-X","article-title":"Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors","volume":"16","author":"Seeman P","year":"1997","unstructured":"Seeman P, Corbett R, Van Tol HH. Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors. Neuropsychopharmacology. 1997, 16:93-110. 10.1016\/S0893-133X(96)00187-X","journal-title":"Neuropsychopharmacology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2011.05.013","article-title":"Delusional infestation: treatment outcome with antipsychotics in 17 consecutive patients (using standardized reporting criteria)","volume":"33","author":"Huber M","year":"2001","unstructured":"Huber M, Lepping P, Pycha R, et al.. Delusional infestation: treatment outcome with antipsychotics in 17 consecutive patients (using standardized reporting criteria). Gen Hosp Psychiatry. 2001, 33:604-611. 10.1016\/j.genhosppsych.2011.05.013","journal-title":"Gen Hosp Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.106.029660","article-title":"Antipsychotic treatment of primary delusional parasitosis","volume":"191","author":"Lepping P","year":"2018","unstructured":"Lepping P, Russell I, Freudenmann RW. Antipsychotic treatment of primary delusional parasitosis. Br J Psychiatry. 2018, 191:198-205. 10.1192\/bjp.bp.106.029660","journal-title":"Br J Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2008.09.014","article-title":"Striatal lesions in delusional parasitosis revealed by magnetic resonance imaging","volume":"32","author":"Huber M","year":"2008","unstructured":"Huber M, Karner M, Kirchler E, et al.. Striatal lesions in delusional parasitosis revealed by magnetic resonance imaging. Progr Neuro-Psychopharmacol Biol Psychiatry. 2008, 32:1967-1971. 10.1016\/j.pnpbp.2008.09.014","journal-title":"Progr Neuro-Psychopharmacol Biol Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.12352","article-title":"Delusional infestation in Parkinson\u2019s disease: a case series","volume":"4","author":"Davis J","year":"2017","unstructured":"Davis J, Kurek J, Sethi K, et al.. Delusional infestation in Parkinson\u2019s disease: a case series. Mov Disord. 2017, 4:111-115. 10.1002\/mdc3.12352","journal-title":"Mov Disord"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.01003","article-title":"Dopamine receptor subtypes, physiology and pharmacology: new ligands and concepts in schizophrenia","author":"Martel JC","year":"2020","unstructured":"Martel JC, Gatti S. Dopamine receptor subtypes, physiology and pharmacology: new ligands and concepts in schizophrenia. Front Pharmacol. 2020, 10.3389\/fphar.2020.01003","journal-title":"Front Pharmacol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/nrn1432","article-title":"The emotional brain","volume":"5","author":"Dalgleish T","year":"2004","unstructured":"Dalgleish T. The emotional brain. Nat Rev. 2004, 5:583-589. 10.1038\/nrn1432","journal-title":"Nat Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2013.07.006","article-title":"Are dopamine D2 receptors out of control in psychosis?","volume":"46","author":"Seeman P","year":"2013","unstructured":"Seeman P. Are dopamine D2 receptors out of control in psychosis?. Prog Neuropsychopharmacol Biol Psychiatry. 2013, 46:146-152. 10.1016\/j.pnpbp.2013.07.006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5949.2010.00162.x","article-title":"All roads to schizophrenia lead to dopamine supersensitivity and elevated dopamine D2(high) receptors","volume":"17","author":"Seeman P","year":"2011","unstructured":"Seeman P. All roads to schizophrenia lead to dopamine supersensitivity and elevated dopamine D2(high) receptors. CNS Neurosci Ther. 2011, 17:118-132. 10.1111\/j.1755-5949.2010.00162.x","journal-title":"CNS Neurosci Ther"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200825080-00004","article-title":"Pathophysiology and treatment of psychosis in Parkinson's disease: a review","volume":"25","author":"Zahodne LB","year":"2008","unstructured":"Zahodne LB, Fernandez HH. Pathophysiology and treatment of psychosis in Parkinson's disease: a review. Drugs Aging. 2008, 25:665-682. 10.2165\/00002512-200825080-00004","journal-title":"Drugs Aging"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62106-6","article-title":"Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial","volume":"383","author":"Cumming J","year":"2014","unstructured":"Cumming J, Isaacson S, Mills R, et al.. Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial. Lancet. 2014, 383:533-540. 10.1016\/S0140-6736(13)62106-6","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2010.12.005","article-title":"Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis","volume":"35","author":"Fusar-Poli P","year":"2011","unstructured":"Fusar-Poli P, Borgwardt S, Crescini A, et al.. Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis. Neurosci Biobehav Rev. 2011, 35:1175-1185. 10.1016\/j.neubiorev.2010.12.005","journal-title":"Neurosci Biobehav Rev"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2012.06.007","article-title":"The neuroanatomy of psychotic diathesis: a meta-analytic review","volume":"46","author":"Palaniyappan L","year":"2012","unstructured":"Palaniyappan L, Balain V, Liddle PF. The neuroanatomy of psychotic diathesis: a meta-analytic review. J Psychiatr Res. 2012, 46:1249-1256. 10.1016\/j.jpsychires.2012.06.007","journal-title":"J Psychiatr Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009363","article-title":"Abnormalities in the white matter tracts in patients with Parkinson disease and psychosis","volume":"94","author":"Lenka A","year":"2020","unstructured":"Lenka A, Ingalhalikar M, Shah A. Abnormalities in the white matter tracts in patients with Parkinson disease and psychosis. Neurology. 2020, 94:1876-1884. 10.1212\/WNL.0000000000009363","journal-title":"Neurology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-017-0071-9","article-title":"Dopamine, psychosis and schizophrenia: the widening gap between basic and clinical neuroscience","volume":"8","author":"Kesby JP","year":"2018","unstructured":"Kesby JP, Eyles DW, McGrath JJ, et al.. Dopamine, psychosis and schizophrenia: the widening gap between basic and clinical neuroscience. Translational Psychiatry. 2018, 8:30. 10.1038\/s41398-017-0071-9","journal-title":"Translational Psychiatry"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1138-17.2019","article-title":"The salience network: a neural system for perceiving and responding to homeostatic demands","volume":"39","author":"Seeley WW","year":"2019","unstructured":"Seeley WW. The salience network: a neural system for perceiving and responding to homeostatic demands. J Neurosci. 2019, 39:9878-9882. 10.1523\/JNEUROSCI.1138-17.2019","journal-title":"J Neurosci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.1.13","article-title":"Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia","volume":"160","author":"Kapur S","year":"2003","unstructured":"Kapur S. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry. 2003, 160:13-23. 10.1176\/appi.ajp.160.1.13","journal-title":"Am J Psychiatry"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2014.10.007","article-title":"Anti-NMDA receptor encephalitis, autoimmunity, and psychosis","volume":"176","author":"Kayser MS","year":"2016","unstructured":"Kayser MS, Dalmau J. Anti-NMDA receptor encephalitis, autoimmunity, and psychosis. Schizophrenia Res. 2016, 176:36-40. 10.1016\/j.schres.2014.10.007","journal-title":"Schizophrenia Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.01086","article-title":"Psychiatric presentation of anti-NMDA receptor encephalitis","volume":"10","author":"Endres D","year":"2019","unstructured":"Endres D, Rauer S, Kern W, et al.. Psychiatric presentation of anti-NMDA receptor encephalitis. Front Neurol. 2019, 10:1086. 10.3389\/fneur.2019.01086","journal-title":"Front Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/50377-delusional-infestation-secondary-to-the-dopamine-agonist-ropirinole-in-a-patient-with-parkinsons-disease-a-case-report-with-an-outline-of-the-biology-of-psychosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:33:01Z","timestamp":1707507181000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/50377-delusional-infestation-secondary-to-the-dopamine-agonist-ropirinole-in-a-patient-with-parkinsons-disease-a-case-report-with-an-outline-of-the-biology-of-psychosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,23]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.12880","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1,23]]}}}